These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
130 related articles for article (PubMed ID: 39007176)
1. Correlation Between Dynamic Spray Plume and Drug Deposition of Solution-Based Pressurized Metered-Dose Inhalers. Zhou Y; Yang B; Hong C; Shao Q; Sun N; Mao Y J Aerosol Med Pulm Drug Deliv; 2024 Oct; 37(5):232-240. PubMed ID: 39007176 [No Abstract] [Full Text] [Related]
2. Spray pattern analysis for metered dose inhalers: effect of actuator design. Smyth H; Brace G; Barbour T; Gallion J; Grove J; Hickey AJ Pharm Res; 2006 Jul; 23(7):1591-6. PubMed ID: 16783475 [TBL] [Abstract][Full Text] [Related]
3. Comparison of the aerosol velocity and spray duration of Respimat Soft Mist inhaler and pressurized metered dose inhalers. Hochrainer D; Hölz H; Kreher C; Scaffidi L; Spallek M; Wachtel H J Aerosol Med; 2005; 18(3):273-82. PubMed ID: 16181002 [TBL] [Abstract][Full Text] [Related]
4. Effect of Pressurized Metered Dose Inhaler Spray Characteristics and Particle Size Distribution on Drug Delivery Efficiency. Yousefi M; Inthavong K; Tu J J Aerosol Med Pulm Drug Deliv; 2017 Oct; 30(5):359-372. PubMed ID: 28463041 [TBL] [Abstract][Full Text] [Related]
5. Spray pattern analysis for metered dose inhalers I: Orifice size, particle size, and droplet motion correlations. Smyth H; Hickey AJ; Brace G; Barbour T; Gallion J; Grove J Drug Dev Ind Pharm; 2006 Oct; 32(9):1033-41. PubMed ID: 17012116 [TBL] [Abstract][Full Text] [Related]
6. The influence of initial atomized droplet size on residual particle size from pressurized metered dose inhalers. Sheth P; Stein SW; Myrdal PB Int J Pharm; 2013 Oct; 455(1-2):57-65. PubMed ID: 23911912 [TBL] [Abstract][Full Text] [Related]
7. The impact of actuator nozzle and surroundings condition on drug delivery using pressurized-metered dose inhalers. Jahed M; Kozinski J; Pakzad L Biomech Model Mechanobiol; 2023 Dec; 22(6):2117-2133. PubMed ID: 37815674 [TBL] [Abstract][Full Text] [Related]
9. Developing an in vitro understanding of patient experience with hydrofluoroalkane-metered dose inhalers. Doub WH; Shah V; Limb S; Guo C; Liu X; Ngo D J Pharm Sci; 2014 Nov; 103(11):3648-3656. PubMed ID: 25228114 [TBL] [Abstract][Full Text] [Related]
10. Modulite: a means of designing the aerosols generated by pressurized metered dose inhalers. Ganderton D; Lewis D; Davies R; Meakin B; Brambilla G; Church T Respir Med; 2002 Aug; 96 Suppl D():S3-8. PubMed ID: 12201079 [TBL] [Abstract][Full Text] [Related]
11. Computational analyses of a pressurized metered dose inhaler and a new drug-aerosol targeting methodology. Kleinstreuer C; Shi H; Zhang Z J Aerosol Med; 2007; 20(3):294-309. PubMed ID: 17894536 [TBL] [Abstract][Full Text] [Related]
12. Increasing the fine particle fraction of pressurised metered dose inhaler solutions with novel actuator shapes. Duke DJ; Nguyen DT; Dos Reis LG; Silva DM; Neild A; Edgington-Mitchell D; Young PM; Honnery DR Int J Pharm; 2021 Mar; 597():120341. PubMed ID: 33545289 [TBL] [Abstract][Full Text] [Related]
13. Optimizing the primary particle size distributions of pressurized metered dose inhalers by using inkjet spray drying for targeting desired regions of the lungs. Ehtezazi T; Davies MJ; Seton L; Morgan MN; Ross S; Martin GD; Hutchings IM Drug Dev Ind Pharm; 2015 Feb; 41(2):279-91. PubMed ID: 24252108 [TBL] [Abstract][Full Text] [Related]
14. Flow Structure and Particle Deposition Analyses for Optimization of a Pressurized Metered Dose Inhaler (pMDI) in a Model of Tracheobronchial Airway. Ahookhosh K; Saidi M; Mohammadpourfard M; Aminfar H; Hamishehkar H; Farnoud A; Schmid O Eur J Pharm Sci; 2021 Sep; 164():105911. PubMed ID: 34129919 [TBL] [Abstract][Full Text] [Related]
15. Influence of the metering chamber volume and actuator design on the aerodynamic particle size of a metered dose inhaler. Berry J; Heimbecher S; Hart JL; Sequeira J Drug Dev Ind Pharm; 2003 Sep; 29(8):865-76. PubMed ID: 14570307 [TBL] [Abstract][Full Text] [Related]
16. The influence of formulation and spacer device on the in vitro performance of solution chlorofluorocarbon-free propellant-driven metered dose inhalers. Smyth HD; Beck VP; Williams D; Hickey AJ AAPS PharmSciTech; 2004 Feb; 5(1):E7. PubMed ID: 15198528 [TBL] [Abstract][Full Text] [Related]
17. The Evolution of Pressurized Metered-Dose Inhalers from Early to Modern Devices. Roche N; Dekhuijzen PN J Aerosol Med Pulm Drug Deliv; 2016 Aug; 29(4):311-27. PubMed ID: 26824873 [TBL] [Abstract][Full Text] [Related]
18. A novel approach to study the pMDI plume using an infrared camera and to evaluate the aerodynamic properties after varying the time between actuations. Kunda NK; Hautmann J; Godoy SE; Marshik P; Chand R; Krishna S; Muttil P Int J Pharm; 2017 Jun; 526(1-2):41-49. PubMed ID: 28450164 [TBL] [Abstract][Full Text] [Related]
19. ProAir(®) HFA delivers warmer, lower-impact, longer-duration plumes containing higher fine particle dose than Ventolin(®) HFA. McCabe JC; Koppenhagen F; Blair J; Zeng XM J Aerosol Med Pulm Drug Deliv; 2012 Apr; 25(2):104-9. PubMed ID: 22191397 [TBL] [Abstract][Full Text] [Related]
20. Effect of Inhalation Flow Rate on Mass-Based Plume Geometry of Commercially Available Suspension pMDIs. Moraga-Espinoza DF; Eshaghian E; Shaver A; Smyth HDC AAPS J; 2018 Jul; 20(5):84. PubMed ID: 30003443 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]